跳至主要内容
临床试验/NCT00851526
NCT00851526已完成不适用

Coronary Bifurcation Stenting (COBIS) Registry in South Korea

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 1,919 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,919
试验地点
1
主要终点
Incidence of the composite outcome of all-cause death, MI, or any PCI/CABG

研究概览

简要总结

The COBIS registry is multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea.

The aim of the study was to find out the current status of bifurcation drug-eluting stenting and determine the prognostic factors for long-term outcome in South Korea.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >= 18 years
  • Any type of de novo bifurcation lesion with a parent vessel >= 2.5 mm and side branch>= 2.0 mm by visual estimation
  • Treated with drug-eluting stent

排除标准

  • Cardiogenic Shock
  • ST elevation MI within 48hours
  • Expected survival less than 1 year
  • Left main bifurcation
  • Allergy to the antiplatelets

结局指标

主要结局

Incidence of the composite outcome of all-cause death, MI, or any PCI/CABG

时间窗: 3 years

次要结局

  • Incidence of stent thrombosis, and periprocedural MI(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyeon-Cheol Gwon

Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验